The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract Surgery
3
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose: To evaluate the effectiveness of cyclosporine 0.05% for dry eye after cataract surgery. Methods: Thirty-two newly diagnosed patients with dry eye syndrome 1 week after cataract surgery received a twice-daily treatment of cyclosporine 0.05% for one eye and normal saline 0.9% for the other. Disease severity was measured at 2 weeks, 1 month, 2 months, and 3 months by Schirmer test I (ST-I), tear film break-up time (tBUT), corneal temperature and dry eye symptom questionnaire (Ocular Surface Disease Index). Results: Both groups increased in ST-I and tBUT over time. ST-I in the cyclosporine 0.05% group showed a significant increase at 3 months and tBUT in the cyclosporine 0.05% group showed an increase at 2 and 3months. The dry eye symptom score was significantly reduced in the cyclosporine 0.05% group. Conclusions: Cyclosporine 0.05% can also be an effective treatment for dry eye after cataract surgery.
Abstract
Purpose: To evaluate the effectiveness of cyclosporine 0.05% for dry eye after cataract surgery. Methods: Thirty-two newly diagnosed patients with dry eye syndrome 1 week after cataract surgery received a twice-daily treatment of cyclosporine 0.05% for one eye and normal saline 0.9% for the other. Disease severity was measured at 2 weeks, 1 month, 2 months, and 3 months by Schirmer test I (ST-I), tear film break-up time (tBUT), corneal temperature and dry eye symptom questionnaire (Ocular Surface Disease Index). Results: Both groups increased in ST-I and tBUT over time. ST-I in the cyclosporine 0.05% group showed a significant increase at 3 months and tBUT in the cyclosporine 0.05% group showed an increase at 2 and 3months. The dry eye symptom score was significantly reduced in the cyclosporine 0.05% group. Conclusions: Cyclosporine 0.05% can also be an effective treatment for dry eye after cataract surgery.
참고문헌 (20)
- Kohlhaas M., "Corneal sensation after cataract and refractive surgery", J Cataract Refract Surg, 24, pp.1399~1409 (1998)
- Li XM, "Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery", Cornea, 26(9), pp.16~20 (2007)
- 조양경, "Dry Eye After Cataract Surgeryand Associated Intraoperative Risk Factors", Korean Journal of Ophthalmology, 23(2), pp.65~73 (2009), 대한안과학회
- Wilson SE, "Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment", Ophthalmology, 114, pp.76~79 (2007)
- Donnenfeld E, "Topical ophthalmic cyclosporine: pharmacology and clinical uses", Surv Ophthalmol, 54, pp.321~338 (2009)
- Thomas PB, "Long-term topical cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis", J Ocul Pharmacol Ther, 25, pp.285~292 (2009)
- Pflugfelder SC, "Antiinflammatory therapy for dry eye", Am J Ophthalmol, 137, pp.337~342 (2004)
- Stern ME, "The role of the lacrimal functional unit in the pathophysiology of dry eye", Exp Eye Res, 78, pp.409~416 (2004)
- Donnenfeld ED, "The effect of hinge position on corneal sensation and dry eye after LASIK", Ophthalmology, 110, pp.1023~1029 (2003)
- "The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye Workshop (2007)", Ocul Surf, 5, pp.75~92 (2007)
- Walker TD., "Benzalkonium toxicity", Clin Experiment Ophthalmol, 32, pp.657~ (2004)
- Sall K, "Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group", Ophthalmology, 107, pp.631~639 (2000)
- Matsuda S, "Mechanisms of action of cyclosporine", Immunopharmacology, 47, pp.119~125 (2000)
- Stern ME, "Conjunctival T-cell subpopulations in Sjogren’s and non-Sjogren’s patients with dry eye", Invest Ophthalmol Vis Sci, 43, pp.2609~2614 (2002)
- Strong B, "Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca", Cornea, 24, pp.80~85 (2005)
- Sahli E, "The effect of topical cyclosporine A on clinical findings and cytological grade of the disease in patients with dry eye", Cornea, 29, pp.1412~1416 (2010)
- Baiza-Duran L, "A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome", Br J Ophthalmol, 94, pp.1312~1315 (2010)
- Tananuvat N, "Controlled study of the use of autologous serum in dry eye patients", Cornea, 20, pp.802~806 (2001)
- Mengher LS, "Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes", Br J Ophthalmol, 70, pp.442~447 (1986)
- Sheppard JD, "Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease", J Ocul Pharmacol Ther, 27, pp.23~27 (2011)